PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29445483-0	2018	Lenalidomide decreased the PSA level for castration-resistant prostate cancer: a case report.	Lenalidomide	0-12	aminopeptidase puromycin sensitive	Homo sapiens	27-30	
25987070-6	2015	Pooled analysis suggested that, in all patients, the pooled PSA level decline of >=50% was 13.3% (13/98) in lenalidomide based regimens.	Lenalidomide	111-123	aminopeptidase puromycin sensitive	Homo sapiens	60-63	
22666210-0	2012	PSA Response to Lenalidomide Therapy in a Pre-Treated Patient with Metastatic Prostate Cancer Refractory to Hormones and Chemotherapy: A Case Report.	Lenalidomide	16-28	aminopeptidase puromycin sensitive	Homo sapiens	0-3	
22666210-4	2012	In this paper, we report that lenalidomide showed antitumoral activity in a patient with HRPC and bone metastases pre-treated with chemotherapy, decreased the PSA level and improved the patient"s health status for the first 5 months.	Lenalidomide	30-42	aminopeptidase puromycin sensitive	Homo sapiens	159-162